Fei Chen

4.9k total citations · 3 hit papers
71 papers, 3.9k citations indexed

About

Fei Chen is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Fei Chen has authored 71 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Cancer Research, 50 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Fei Chen's work include Cancer-related molecular mechanisms research (24 papers), MicroRNA in disease regulation (20 papers) and NF-κB Signaling Pathways (19 papers). Fei Chen is often cited by papers focused on Cancer-related molecular mechanisms research (24 papers), MicroRNA in disease regulation (20 papers) and NF-κB Signaling Pathways (19 papers). Fei Chen collaborates with scholars based in China, United States and Sweden. Fei Chen's co-authors include Vince Castranova, Xianglin Shi, Laurence M. Demers, Yadong Zhang, Shicheng Su, Di Huang, Erwei Song, Qiang Liu, Jinghua Zhao and Linbin Yang and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Fei Chen

67 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New Insights into the Role of Nuclear Factor-κB, a Ubiquitous Transcription Factor in the Initiation of Diseases

1999 622 citations Fei Chen, Vince Castranova et al. profile →
Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells

2019 581 citations Fei Chen et al. profile →
NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death

2018 345 citations Fei Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fei Chen China	30	2.5k	2.1k	777	526	316	71	3.9k
Concetta Bubici United States	21	2.2k 0.9×	1.1k 0.5×	822 1.1×	756 1.4×	338 1.1×	29	3.8k
Chiao‐Wen Lin Taiwan	39	2.7k 1.1×	1.4k 0.6×	449 0.6×	905 1.7×	307 1.0×	176	4.4k
Juan Lü China	36	2.7k 1.1×	1.9k 0.9×	461 0.6×	712 1.4×	516 1.6×	143	4.1k
Tobias Schmid Germany	32	2.0k 0.8×	1.3k 0.6×	910 1.2×	504 1.0×	238 0.8×	97	3.8k
Pei Ma China	33	3.4k 1.4×	2.4k 1.1×	384 0.5×	439 0.8×	640 2.0×	102	4.7k
Xiaoli Li China	34	1.8k 0.7×	866 0.4×	652 0.8×	422 0.8×	215 0.7×	172	3.3k
Yanfang Liu China	33	2.5k 1.0×	1.3k 0.6×	904 1.2×	824 1.6×	527 1.7×	206	4.4k
Li Zhao China	30	2.4k 1.0×	1.1k 0.5×	368 0.5×	644 1.2×	298 0.9×	103	3.8k
Sheng Tai China	29	1.7k 0.7×	1.0k 0.5×	786 1.0×	478 0.9×	528 1.7×	110	3.6k

Countries citing papers authored by Fei Chen

Since Specialization

Citations

This map shows the geographic impact of Fei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Chen more than expected).

Fields of papers citing papers by Fei Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Chen. The network helps show where Fei Chen may publish in the future.

Co-authorship network of co-authors of Fei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Chen. A scholar is included among the top collaborators of Fei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Chen. Fei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Fei, et al.. (2026). A genetically encoded device for transcriptome storage in mammalian cells. Science. 391(6792). eadz9353–eadz9353.

Zhao, Siqi, Minjie Chen, Fei Chen, et al.. (2025). ENTPD8 overexpression enhances anti-PD-L1 therapy in hepatocellular carcinoma via miR-214-5p inhibition. iScience. 28(2). 111819–111819.

Seno, Akimasa, Zhuoyue Bi, Lisa Polin, et al.. (2025). Genome-wide mapping of arsenic-activated Nrf2 reveals metabolic and epigenetic reprogramming in induced pluripotent stem cells. Redox Biology. 86. 103773–103773. 2 indexed citations

Chen, Huijiao, Dejuan Wang, Zheng Jiang, et al.. (2025). Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial. Nature Communications. 16(1). 8918–8918.

Ding, Yuanhao, Qingxia Wu, Zhiyang Li, et al.. (2025). Transcriptome and metabolome analysis reveals the mechanism of key nutrient formation in Hainan oil-camellia (Camellia hainanica) growth cycle. Industrial Crops and Products. 230. 121122–121122. 1 indexed citations

Li, Xiaoyu, Jianwei Huang, Xi Chen, et al.. (2024). Lnc00113 promotes triple‐negative breast cancer progression via the NOB‐1/MAPK signaling axis. The Journal of Gene Medicine. 26(2). 1 indexed citations

Liao, Xiwen, Xinhua Chen, Weifeng Hong, et al.. (2024). 83P Effectiveness and safety of neoadjuvant immunochemotherapy with and without surgery in patients with resectable esophageal squamous cell carcinoma: A retrospective cohort study. Immuno-Oncology Technology. 24. 100826–100826.

Hu, Lingyu, et al.. (2024). Hyaluronic Acid-Modified and Doxorubicin-Loaded Au Nanorings for Dual-Responsive and Dual-Imaging Guided Targeted Synergistic Photothermal Chemotherapy Against Pancreatic Carcinoma. International Journal of Nanomedicine. Volume 19. 13429–13442. 1 indexed citations

Wang, Qinchuan, Minjun Dong, Fei Chen, et al.. (2023). Analysis of neoadjuvant chemotherapy for breast cancer: a 20-year retrospective analysis of patients of a single institution. BMC Cancer. 23(1). 984–984. 4 indexed citations

10.

Song, Yunjia, et al.. (2021). Shenlijia Attenuates Doxorubicin-Induced Chronic Heart Failure by Inhibiting Cardiac Fibrosis. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 10 indexed citations

11.

Wang, Liang, Meijun Li, & Fei Chen. (2021). microRNA-26a represses pancreatic cancer cell malignant behaviors by targeting E2F7. Discover Oncology. 12(1). 55–55. 14 indexed citations

12.

Xie, Ying, Fei Chen, Xu Liu, et al.. (2019). LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer. World Journal of Gastroenterology. 25(29). 3972–3984. 53 indexed citations

13.

Jiang, Yue, Fei Chen, Na Qin, et al.. (2017). Potentially functional variants in lncRNAs are associated with breast cancer risk in a Chinese population. Molecular Carcinogenesis. 56(9). 2048–2057. 9 indexed citations

14.

Chen, Fei, et al.. (2017). Deep sequencing profiles MicroRNAs related to Aspergillus fumigatus infection in lung tissues of mice. Journal of Microbiology Immunology and Infection. 52(1). 90–99. 6 indexed citations

15.

Chen, Fei, Yuhong Li, Yanhong Feng, Xiuli He, & Liang Wang. (2016). Evaluation of Antimetastatic Effect of lncRNA-ATB siRNA Delivered Using Ultrasound-Targeted Microbubble Destruction. DNA and Cell Biology. 35(8). 393–397. 17 indexed citations

16.

Chen, Fei & Vince Castranova. (2007). Nuclear Factor-κB, an Unappreciated Tumor Suppressor. Cancer Research. 67(23). 11093–11098. 62 indexed citations

17.

Chen, Fei, Yongju Lu, Vince Castranova, Zhiwei Li, & Michael Karin. (2006). Loss of Ikkβ Promotes Migration and Proliferation of Mouse Embryo Fibroblast Cells. Journal of Biological Chemistry. 281(48). 37142–37149. 29 indexed citations

18.

Chen, Fei. (2005). Is NF-κB a culprit in type 2 diabetes?. Biochemical and Biophysical Research Communications. 332(1). 1–3. 30 indexed citations

19.

Hernández‐Hoyos, Gabriela, et al.. (1998). Chromatin remodeling of the interleukin-2 gene: Distinct alterations in the proximal versus distal enhancer regions. Nucleic Acids Research. 26(12). 2923–2934. 75 indexed citations

20.

Chen, Fei, et al.. (1995). Essential Role of NF-κB Activation in Silica-Induced Inflammatory Mediator Production in Macrophages. Biochemical and Biophysical Research Communications. 214(3). 985–992. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact